Sector
PharmaceuticalsOpen
₹1,034Prev. Close
₹1,034Turnover(Lac.)
₹5.71Day's High
₹1,049.2Day's Low
₹1,03452 Week's High
₹2,777.9552 Week's Low
₹957Book Value
₹454.59Face Value
₹5Mkt Cap (₹ Cr.)
648.41P/E
35.54EPS
29.34Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 259.72 | 222.43 | 203.48 | 152.36 |
Net Worth | 262.81 | 225.52 | 206.57 | 155.45 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 318.66 | 258.18 | 152.18 | 113.65 |
yoy growth (%) | 23.42 | 69.65 | 33.89 | 13.97 |
Raw materials | -148.31 | -102.5 | -64.8 | -45.86 |
As % of sales | 46.54 | 39.7 | 42.58 | 40.35 |
Employee costs | -33.05 | -27.23 | -23.8 | -18.37 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 68.97 | 75.99 | 14.35 | 17.8 |
Depreciation | -7.67 | -7.39 | -7.26 | -4.56 |
Tax paid | -16.72 | -20.52 | -3.74 | -5.2 |
Working capital | 39.27 | 16.39 | 25.59 | -4.17 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 23.42 | 69.65 | 33.89 | 13.97 |
Op profit growth | -14.49 | 273.41 | -3.79 | -15.26 |
EBIT growth | -9.38 | 368.73 | -14.21 | -17.74 |
Net profit growth | -5.81 | 423.11 | -15.79 | -15.4 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 368.26 | 338.69 | 278.08 | 317.5 | 257.97 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 368.26 | 338.69 | 278.08 | 317.5 | 257.97 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 8.63 | 14.13 | 5.53 | 10.68 | 8.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Rahul J Nachane
Whole Time Director & CFO
Rajesh N Lawande
Non-Exec & Non-Independent Dir
Ajita Nachane
Non-Exec. & Independent Dir.
Jayaram Sitaram
Company Sec. & Compli. Officer
Pallavi Pednekar
Independent Director
Sarala Menon
Chairman & Independent Directo
Dhananjay Mungale
Additional Director
S R Deo
301 E Square Subhash Road,
Vile Parle (East),
Maharashtra - 400057
Tel: +91-22-2663 6450
Website: http://www.nglfinechem.com
Email: [email protected]
Shiv Shakti Indust,
Unit No 9 Lower Pare, 7 B J R Boricha Marg,
Mumbai-400011
Tel: 91-022-23016761
Website: www.purvashare.com
Email: [email protected]
Summary
NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra. The Company became a Public Limited Company. The Company has got its registered of...
Read More
Reports by NGL Fine Chem Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.